Alessandro Di Federico: Clinicogenomic Features of Pulmonary Sarcomatoid Carcinoma
Alessandro Di Federico, Medical Oncologist and Ph.D. student at the University of Bologna, shared a post on LinkedIn about recent article he and his colleagues authored:
“Pulmonary sarcomatoid carcinoma is a rare lung cancer histology that every thoracic oncologist has encountered – or will encounter – in their clinical practice.
In this collaborative study led by Dr. Lingzhi Hong and Dr. Natalie Vokes at MD Anderson Cancer Center, we characterized clinicopathologic characteristics, genomic features, and outcomes to immunotherapy or chemoimmunotherapy of patients affected by these tumors.”
Title: Distinct Clinicogenomic Features and Immunotherapy Associations in Pulmonary Sarcomatoid Carcinoma: A Multi-Center Retrospective Study
Authors: Lingzhi Hong, Alessandro Di Federico, Bolun Liu, Alissa J. Cooper, Joao V. Alessi, Phoebe Clark, Waree Rinsurongkawong, Chingyi Young, Hui Li, Kang Qin, Muhammad Aminu, Yasir Elamin, Boris Sepesi, Jeff Lewis, Don L. Gibbons, Ara A. Vaporciyan, J. Jack Lee, Xiuning Le, Jia Wu, Sinchita Roy-Chowdhuri, Mark J. Routbort, P Andrew Futreal, John V. Heymach, Mark M. Awad, Adam J. Schoenfeld, Jianjun Zhang, Biagio Ricciuti, Lei Deng, Natalie I. Vokes
More posts featuring Alessandro Di Federico on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023